Published in Mol Cell Biol on October 01, 2000
Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer (2008) 3.16
TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A (2008) 2.58
Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene (2002) 1.91
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. Eur Urol (2015) 1.90
Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev (2010) 1.88
Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev (2013) 1.77
Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci U S A (2003) 1.74
Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell (2009) 1.73
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell (2013) 1.73
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J (2007) 1.52
RB: mitotic implications of a tumour suppressor. Nat Rev Cancer (2012) 1.51
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div (2012) 1.46
The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene (2006) 1.41
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res (2004) 1.33
The retinoblastoma protein induces apoptosis directly at the mitochondria. Genes Dev (2013) 1.28
Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology (2010) 1.26
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife (2014) 1.26
Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J (2010) 1.25
The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J (2001) 1.25
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells. Cancer Res (2007) 1.23
Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts? Cell Div (2007) 1.22
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget (2015) 1.20
Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol (2006) 1.16
p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage. Cancer Res (2009) 1.15
DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep (2006) 1.14
The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system. Nat Rev Cancer (2008) 1.08
Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase. Mol Cell Biol (2001) 1.05
Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol Cell Biol (2007) 1.04
CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Cell Cycle (2013) 1.04
DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol Cell Biol (2011) 1.03
Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J Cell Biol (2002) 1.02
RB reversibly inhibits DNA replication via two temporally distinct mechanisms. Mol Cell Biol (2004) 1.01
Tumour suppressor genes in chemotherapeutic drug response. Biosci Rep (2012) 0.99
Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult. Cancer Res (2006) 0.99
Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo. Neoplasia (2009) 0.98
cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell (2005) 0.97
Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control. J Biol Chem (2009) 0.97
Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression. Mol Cell Biol (2006) 0.97
Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy? Cancer Metab (2014) 0.97
RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A (2002) 0.96
The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner. PLoS One (2008) 0.96
Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mol Cancer (2010) 0.96
RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1. Oncogene (2009) 0.95
Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochim Biophys Acta (2009) 0.95
Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer. Nat Rev Urol (2011) 0.94
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J Clin Invest (2012) 0.91
Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain. PLoS One (2006) 0.91
The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes. Oncogene (2005) 0.91
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy (2013) 0.89
RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo. Mol Biol Cell (2011) 0.89
Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells. Sci Rep (2015) 0.88
Elevated poly-(ADP-ribose)-polymerase activity sensitizes retinoblastoma-deficient cells to DNA damage-induced necrosis. Mol Cancer Res (2009) 0.88
Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp Cell Res (2009) 0.87
Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis (2013) 0.86
Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget (2015) 0.85
Differential role of RB in response to UV and IR damage. Nucleic Acids Res (2005) 0.83
Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition. Cell Cycle (2012) 0.82
Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer. Br J Cancer (2003) 0.82
Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP). J Biol Chem (2011) 0.82
The pro-apoptotic activity of Drosophila Rbf1 involves dE2F2-dependent downregulation of diap1 and buffy mRNA. Cell Death Dis (2014) 0.82
RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer. Cell Cycle (2015) 0.82
PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells. Int J Oncol (2010) 0.81
Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug. PLoS One (2011) 0.80
Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax. Cell Cycle (2014) 0.78
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness. Clin Cancer Res (2014) 0.78
Responses of genes involved in cell cycle control to diverse DNA damaging chemicals in human lung adenocarcinoma A549 cells. Cancer Cell Int (2005) 0.78
RB activity alters checkpoint response and chemosensitivity in lung cancer lines. J Surg Res (2007) 0.78
The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas. Mol Cell Biol (2015) 0.77
Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage. Cell Death Dis (2015) 0.77
Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Cancer Biol Ther (2016) 0.75
Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth. Elife (2016) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Cancer cell cycles. Science (1996) 21.29
Histone acetylation in chromatin structure and transcription. Nature (1997) 14.64
MCM proteins in DNA replication. Annu Rev Biochem (1999) 13.88
Cell cycle checkpoints: preventing an identity crisis. Science (1996) 13.74
The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science (1988) 11.90
Cell cycle control and cancer. Science (1994) 10.90
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (1995) 8.53
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (1994) 8.22
Cyclin A is required at two points in the human cell cycle. EMBO J (1992) 7.96
Rb interacts with histone deacetylase to repress transcription. Cell (1998) 7.22
Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature (1998) 6.87
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol (1995) 6.41
A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell (1995) 6.00
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell (1999) 4.94
Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A (1980) 4.64
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol (1998) 4.54
Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell (2000) 4.48
Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (1995) 4.05
Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev (1999) 3.22
Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem (1997) 3.18
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol (1996) 3.15
DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell (1998) 3.04
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
RAD9-dependent G1 arrest defines a second checkpoint for damaged DNA in the cell cycle of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1993) 2.70
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
Control of pRB phosphorylation. Curr Opin Genet Dev (1998) 2.49
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell (1999) 2.48
DNA damage checkpoints update: getting molecular. Curr Opin Genet Dev (1998) 2.44
Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol (1993) 2.37
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol (1997) 2.25
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem (1996) 2.23
Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol (1995) 2.11
Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci U S A (1999) 2.10
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol (1999) 1.86
BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci U S A (2000) 1.85
The retinoblastoma tumor suppressor protein. Adv Cancer Res (1994) 1.72
Functions of the retinoblastoma protein. Bioessays (1999) 1.50
Role of the Rb/E2F pathway in cell growth control. J Cell Physiol (1997) 1.44
Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem (1997) 1.40
The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res (1997) 1.35
pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F. Oncogene (1998) 1.30
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol Biol Cell (1996) 1.24
Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci U S A (1995) 1.23
Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest. J Biol Chem (1999) 1.17
Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res (1991) 1.09
Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene (2000) 1.00
Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. Oncogene (1993) 0.98
S phase damage sensing checkpoints in mammalian cells. Cancer Surv (1997) 0.94
Rapid dephosphorylation of p107 following UV irradiation. Oncogene (1999) 0.94
Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250. Mol Cell Biol (1999) 0.82
Unscheduled DNA synthesis in cultured ataxia telangiectasia fibroblast-like cells. Mutat Res (1980) 0.81
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A (1983) 6.00
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (1999) 5.33
Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (1986) 4.99
Microinjection and localization of a 130K protein in living fibroblasts: a relationship to actin and fibronectin. Cell (1980) 4.87
Rapid purification of mammalian 70,000-dalton stress proteins: affinity of the proteins for nucleotides. Mol Cell Biol (1985) 4.75
Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell (1989) 4.68
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
A rapid purification of alpha-actinin, filamin, and a 130,000-dalton protein from smooth muscle. J Biol Chem (1980) 4.50
Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle. J Biol Chem (1982) 4.42
Nuclear and nucleolar localization of the 72,000-dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem (1984) 4.20
Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell (2000) 3.91
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Phosphotyrosine-containing proteins are concentrated in focal adhesions and intercellular junctions in normal cells. Proc Natl Acad Sci U S A (1985) 3.76
Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell (1985) 3.73
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell (1997) 3.54
10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin. J Cell Biol (1984) 3.51
Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (1996) 3.37
Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell (1999) 3.30
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (1997) 2.98
Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg (2001) 2.96
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol (2000) 2.96
Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell (1999) 2.90
Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell (1993) 2.80
Purification of the major mammalian heat shock proteins. J Biol Chem (1982) 2.79
Biochemical characterization of the mammalian stress proteins and identification of two stress proteins as glucose- and Ca2+-ionophore-regulated proteins. J Biol Chem (1983) 2.78
Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein. Mol Cell Biol (1985) 2.74
Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A (1998) 2.73
Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol (1988) 2.72
Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell (2001) 2.69
Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene (2006) 2.57
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55
Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med (2001) 2.51
The common 90-kd protein component of non-transformed '8S' steroid receptors is a heat-shock protein. EMBO J (1985) 2.50
Non-muscle alpha actinins are calcium-sensitive actin-binding proteins. Nature (1981) 2.35
Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem (1978) 2.33
The mouse c-abl locus: molecular cloning and characterization. Cell (1984) 2.33
Direct visualization of fluorescein-labeled microtubules in vitro and in microinjected fibroblasts. J Cell Biol (1981) 2.33
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol (1997) 2.25
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem (1996) 2.23
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev (2000) 2.21
Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc Natl Acad Sci U S A (1996) 2.19
Molecular and cellular effects of heat-shock and related treatments of mammalian tissue-culture cells. Cold Spring Harb Symp Quant Biol (1982) 2.18
A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol (1993) 2.18
Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci U S A (1993) 2.17
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene (2010) 2.14
Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J (1989) 2.13
Fluorescent localization of contractile proteins in tissue culture cells. Methods Enzymol (1982) 2.12
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol (1991) 2.06
Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol Cell Biol (1988) 2.00
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J (1993) 2.00
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99
Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc Natl Acad Sci U S A (1990) 1.99
Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell (1981) 1.98
Microinjection of fluorescently labeled alpha-actinin into living fibroblasts. Proc Natl Acad Sci U S A (1979) 1.95
HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem (1993) 1.91
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res (2000) 1.91
A Rab1 mutant affecting guanine nucleotide exchange promotes disassembly of the Golgi apparatus. J Cell Biol (1994) 1.91
Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus. J Virol (1982) 1.90
Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase. J Biol Chem (1980) 1.88
Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrob Agents Chemother (1998) 1.86
BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci U S A (2000) 1.85
Kinetics of receptor modification. The multiply methylated aspartate receptors involved in bacterial chemotaxis. J Biol Chem (1986) 1.84
Cyclin B targets p34cdc2 for tyrosine phosphorylation. EMBO J (1991) 1.83
Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem (2000) 1.77
Are cattle, sheep, and goats endangered species? Mol Ecol (2007) 1.74
Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues. J Biol Chem (1982) 1.74
Hemorrhoidectomy with self-retaining retraction. Dis Colon Rectum (1996) 1.73
Cervical facet dislocation: techniques for ventral reduction and stabilization. J Neurosurg (2000) 1.72
The retinoblastoma tumor suppressor protein. Adv Cancer Res (1994) 1.72
Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J Biol Chem (2001) 1.71
Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines. Mol Cell Biol (1988) 1.70
Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. J Biol Chem (1985) 1.70
ENCORE: the effect of nutrient enrichment on coral reefs. Synthesis of results and conclusions. Mar Pollut Bull (2001) 1.69
Protein tyrosine phosphorylation in the cell cycle of BALB/c 3T3 fibroblasts. Proc Natl Acad Sci U S A (1986) 1.69
Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence. Mol Cell Biol (1983) 1.69
Elevation of tubulin levels by microinjection suppresses new tubulin synthesis. Nature (1983) 1.68
Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci (1999) 1.68
Ipsilateral shoulder pain after thoracotomy with epidural analgesia: the influence of phrenic nerve infiltration with lidocaine. Anesth Analg (2001) 1.67
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature (1988) 1.66
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A (2001) 1.64
The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae. J Gen Virol (1990) 1.64
Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol Cell Biol (1989) 1.64
Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature (1984) 1.62
Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature (1985) 1.61
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem (1983) 1.61
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol (1999) 1.57
Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science (1992) 1.56
Characterization of antibodies to smooth muscle myosin kinase and their use in localizing myosin kinase in nonmuscle cells. Proc Natl Acad Sci U S A (1981) 1.55
Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy (1994) 1.54
A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci U S A (1994) 1.53
Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc Natl Acad Sci U S A (1995) 1.52
Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev (1995) 1.50